Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jose M Rubio

Showing results (31-40 of 74) with videos related to

Pageof 8
Sort By:
The Journal of Nervous and Mental Disease|March 21, 2014
Effect of first episode axis I disorders on quality of lifeJose M Rubio, Mark Olfson, Gabriela Pérez-Fuentes, et al.
The Journal of Infectious Diseases|May 7, 2002
Relapses versus reinfections in patients coinfected with Leishmania infantum and human immunodeficiency virus type 1Miguel A Morales, Israel Cruz, Jose M Rubio, et al.
The American Journal of Psychiatry|February 19, 2025
Continuous Dopamine D<sub>2</sub> Receptor Blockade and Long-Term Outcome in First-Episode SchizophreniaJari Tiihonen, Antti Tanskanen, Marco Solmi, et al.
Schizophrenia Bulletin|May 9, 2026
Persistent Psychosis During 4 Years after First Hospitalization for a Psychotic Disorder in the Suffolk County Mental Health Project: Prevalence, Risk Factors, and Relationship to 25-Year OutcomesJose M Rubio, Wenxuan Lian, Evelyn J Bromet, et al.
European Journal of Nutrition|August 24, 2015
Effects of an antioxidant beverage on biomarkers of oxidative stress in Alzheimer's patientsJose M Rubio-Perez, Maria D Albaladejo, Pilar Zafrilla, et al.
Schizophrenia Bulletin|May 20, 2021
Risk Factors, Incidence, and Outcomes of Neuroleptic Malignant Syndrome on Long-Acting Injectable vs Oral Antipsychotics in a Nationwide Schizophrenia CohortDaniel Guinart, Heidi Taipale, Jose M Rubio, et al.
The Journal of Clinical Psychiatry|February 15, 2023
Predictors for Initiation of Atypical Long-Acting Injectable Antipsychotic Agents in a Commercial Claims Cohort of Individuals With Early-Phase SchizophreniaJose M Rubio, Marko A Mychaskiw, Sangtaeck Lim, et al.
JAMA Psychiatry|May 18, 2017
Efficacy of 42 Pharmacologic Cotreatment Strategies Added to Antipsychotic Monotherapy in Schizophrenia: Systematic Overview and Quality Appraisal of the Meta-analytic EvidenceChristoph U Correll, Jose M Rubio, Gabriella Inczedy-Farkas, et al.
Neuroimage|June 26, 2023
Effects of phase encoding direction on test-retest reliability of human functional connectomeHengyi Cao, Anita D Barber, Jose M Rubio, et al.
JMIR Formative Research|November 10, 2022
Digital Technology in Psychiatry: Survey Study of CliniciansWilliam Andrew Sterling, Michael Sobolev, Anna Van Meter, et al.
Pageof 8

Showing results (31-40 of 74) with videos related to

Sort By:
Pageof 8
The Journal of Nervous and Mental Disease|March 21, 2014
Effect of first episode axis I disorders on quality of lifeJose M Rubio, Mark Olfson, Gabriela Pérez-Fuentes, et al.
The Journal of Infectious Diseases|May 7, 2002
Relapses versus reinfections in patients coinfected with Leishmania infantum and human immunodeficiency virus type 1Miguel A Morales, Israel Cruz, Jose M Rubio, et al.
The American Journal of Psychiatry|February 19, 2025
Continuous Dopamine D<sub>2</sub> Receptor Blockade and Long-Term Outcome in First-Episode SchizophreniaJari Tiihonen, Antti Tanskanen, Marco Solmi, et al.
Schizophrenia Bulletin|May 9, 2026
Persistent Psychosis During 4 Years after First Hospitalization for a Psychotic Disorder in the Suffolk County Mental Health Project: Prevalence, Risk Factors, and Relationship to 25-Year OutcomesJose M Rubio, Wenxuan Lian, Evelyn J Bromet, et al.
European Journal of Nutrition|August 24, 2015
Effects of an antioxidant beverage on biomarkers of oxidative stress in Alzheimer's patientsJose M Rubio-Perez, Maria D Albaladejo, Pilar Zafrilla, et al.
Schizophrenia Bulletin|May 20, 2021
Risk Factors, Incidence, and Outcomes of Neuroleptic Malignant Syndrome on Long-Acting Injectable vs Oral Antipsychotics in a Nationwide Schizophrenia CohortDaniel Guinart, Heidi Taipale, Jose M Rubio, et al.
The Journal of Clinical Psychiatry|February 15, 2023
Predictors for Initiation of Atypical Long-Acting Injectable Antipsychotic Agents in a Commercial Claims Cohort of Individuals With Early-Phase SchizophreniaJose M Rubio, Marko A Mychaskiw, Sangtaeck Lim, et al.
JAMA Psychiatry|May 18, 2017
Efficacy of 42 Pharmacologic Cotreatment Strategies Added to Antipsychotic Monotherapy in Schizophrenia: Systematic Overview and Quality Appraisal of the Meta-analytic EvidenceChristoph U Correll, Jose M Rubio, Gabriella Inczedy-Farkas, et al.
Neuroimage|June 26, 2023
Effects of phase encoding direction on test-retest reliability of human functional connectomeHengyi Cao, Anita D Barber, Jose M Rubio, et al.
JMIR Formative Research|November 10, 2022
Digital Technology in Psychiatry: Survey Study of CliniciansWilliam Andrew Sterling, Michael Sobolev, Anna Van Meter, et al.
Pageof 8